Mosby's 2027 Nursing Drug Reference - Elsevier E-Book on VitalSource, 40th Edition

by Linda Skidmore-Roth, RN, MSN, NP

Elsevier eBook on VitalSource

ISBN: 9780443385490

Publication Date: 04-20-2026

Page Count: 1488

Imprint: Mosby

List Price: $42.99

$42.99

Or $0.00 with a valid access code

Choose the drug handbook trusted by nurses for over 35 years! Mosby's 2027 Nursing Drug Reference makes it easy to find the most vital information on the drugs you administer most frequently. More than 5,000 drugs are profiled — including more than 22 new entries for drugs recently approved by the FDA. And no other drug guide places a higher emphasis on patient safety, with Black Box Warnings for dangerous adverse reactions, High Alerts for drugs with the greatest risk, and a focus on both common and life-threatening side effects. From nursing pharmacology expert Linda Skidmore-Roth, this perennial bestseller proves there is a difference in drug guides.

Related Products
- 40th Edition
  Evolve Resources for Mosby's 2027 Nursing Drug Reference
  Resources
  
  ISBN: 9780443385513
Key Features
- Content on more than 5,000 generic and trade name drugs covers almost every drug you are likely to encounter in clinicals
- Black Box Warning feature alerts you to FDA warnings of potentially life-threatening reactions
- Safety Alert feature icon highlights the most critical interactions and side-effects that you must be aware of during clinicals
- Bold coverage of IV drug administration helps you easily find appropriate dosage and IV administration instructions to safely administer these drugs
- Side effects information is organized by body system and identified as common or life-threatening, showing signs to watch for during assessments
- Nursing Process steps are used as the framework to organize all nursing care information, helping you learn how to easily and completely incorporate the nursing process into your clinical experiences
- Logical alphabetical organization by generic name with both trade and generic names in the index provides quick access to information on specific drugs
- Complete pharmacokinetic information is summarized in a table and includes the mechanism and absorption of the drug as well as its action, duration, and excretion
- Drugs covered in the appendixes are cross-referenced with headers in the book, making it easier to quickly find content for drugs not addressed in the body of the book
- More than 100 Evolve-only drug monographs provide valuable information on lesser used medications
New to This Edition
- NEW! More than 22 monographs on newly released, FDA-approved drugs provide up-to-date information on the latest drug therapies
- UPDATED! More than 20 new drugs have been added to the Evolve-only drug monographs
- UPDATED! Completely reviewed and revised drug monographs cover new interactions, precautions, alerts, patient teaching instructions, and other need-to-know information, boosting your confidence in the accuracy of the information and helping you prevent medication dispensing errors
Contents

INDIVIDUAL DRUG MONOGRAPHS
APPENDICES
A. Selected New Drugs
B. Ophthalmic, Nasal, Topical, and Otic Products
C. Vaccines and Toxoids
D. Recent FDA Drug Approvals
Authors

Linda Skidmore-Roth, RN, MSN, NP, Consultant, Littleton, Colorado; Former Nursing Faculty, New Mexico State University, Las Cruces, New Mexico; El Paso Community College, El Paso, Texas, USA
Accessibility
- Ways of Reading
  - The appearance of the text and page layout can be modified according to the capabilities of the reading system (font family and font size, spaces between paragraphs, sentences, words, and letters, as well as color of background and text)
  - This e-publication is accessible to the full extent that the file format and types of content allow, on a specific reading device, by default, without necessarily including any additions such as textual descriptions of images or enhanced navigation
  - No information about nonvisual reading is available
- Conformance
  - No information is available
- Navigation
  - Table of contents to all chapters of the text via links
  - Page list to go to pages from the print source version
- Rich Content
  - No information is available
- Hazards
  - No information is available
- Product Content
  - No information is available
- Legal Considerations
  - No information is available
- Additional Accessibility Information
  - Content is enhanced with ARIA roles to optimize organization and facilitate navigation
  - Page breaks included from the original print source
  - For readers with color vision deficiency, use of color (e.g., in diagrams, graphics and charts, in prompts, or on buttons inviting a response) is not the sole means of graphical distinction or of conveying information
  - E-publication includes basic navigation (usually less detailed than TOC-based navigation)
  - Where links, controls or buttons are included in the content, the purpose or functionality of each link, control or button is apparent from the associated text alone - or where it is unclear, separate link, control or button descriptions are provided
  - All (or substantially all) textual matter is arranged in a single logical reading order (including text that is visually presented as separate from the main text flow, e.g., in boxouts, captions, tables, footnotes, endnotes, citations, etc.). Non-textual content is also linked from within this logical reading order. (Purely decorative non-text content can be ignored).
  - The language of the text has been specified (e.g., via the HTML or XML lang attribute) to optimise text-to-speech (and other alternative renderings), both at the whole document level and, where appropriate, for individual words, phrases or passages in a different language.